Previous 10 | Next 10 |
ENGLEWOOD, CO / ACCESSWIRE / July 22, 2019 / Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today provided an update on the company’s clinical development programs and transition to a new U.S. business model, and also a...
Company also announces expansion of distribution network targeting gynecology practices in the Middle East through partnership with Dansys Group ENGLEWOOD, CO / ACCESSWIRE / June 25, 2019 / Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate he...
ENGLEWOOD, CO / ACCESSWIRE / June 11, 2019 / Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer and director, will present at the Raymond James Life Sciences and MedTech Conference. ...
Viveve Medical, Inc. (VIVE) Q1 2019 Earnings Conference Call May 9, 2019 17:00 ET Company Participants Jeannie Swindle - Senior Director of Corporate Communications Scott Durbin - CEO James Atkinson - Chief Business Officer & President Conference Call Participants Josh ...
Viveve Medical (NASDAQ: VIVE ): Q1 GAAP EPS of -$0.22 beats by $0.07 . More news on: Viveve Medical, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
- Successful organizational realignment resulting in decreased operating expenses - Significant progress in clinical programs targeting expanded indications in sexual function and stress urinary incontinence ENGLEWOOD, CO / ACCESSWIRE / May 9, 2019 / Viveve Medical Inc. (NASDAQ: VIVE)...
On 3/5/19 we published a bearish report on T2 Biosystems ( TTOO ) with a 12-month target of $1.50. However, that target now looks conservative. We now believe TTOO could tumble to around $0.50 within a year, similar to how Viveve Medical ( VIVE ) has tumbled lower than our $0.90 price targe...
Establishment Labs Could Become The Next Hot Medtech Growth Stock Establishment Labs ( ESTA ) manufactures and sells medical devices for aesthetic and reconstructive plastic surgery. It primarily offers silicone gel-filled smooth category breast implants under the Motiva Implants brand nam...
ENGLEWOOD, CO / ACCESSWIRE / May 2, 2019 / Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that it will report its first quarter 2019 financial and operating results after the close of the U.S. financial markets on Thursda...
Viveve 2.0 system and its consumable treatment tips can now be sold in over 30 countries in addition to the United States ENGLEWOOD, CO / ACCESSWIRE / April 11, 2019 / Viveve Medical Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced th...
News, Short Squeeze, Breakout and More Instantly...
Novonix Limited (NVNXF) is expected to report for quarter end 2023-12-31 MedAvail Holdings Inc. (MDVL) is expected to report for Q3 2023 Nobility Homes, Inc. (NOBH) is expected to report for quarter end 2023-10-31 Walgreens Boots Alliance Inc. (WBA) is expected to report $0.66 for Q1 ...
Disco Corporation ADR (DSCSY) is expected to report for Q2 2024 Sonic Foundry Inc. (SOFO) is expected to report for quarter end 2023-09-30 Sono Group N.V. (SEVCQ) is expected to report for quarter end 2023-09-30 Minim Inc (MINM) is expected to report for Q3 2023 Enel Spa ADR (ENLA...
Enel Spa ADR (ENLAY) is expected to report for Q3 2023 LEG Immobilien SE Registered Shares (LEGIF) is expected to report for Q3 2023 G. Willi-Food International Ltd. (WILC) is expected to report for Q3 2023 Worthington Steel Inc. (WS) is expected to report $0.15 for Q2 2024 Sonic ...